Ticker Scorecard - LFCR Basics Company: Lifecore Biomedical, Inc. IPO Date: March 1, 1996 Sector: Healthcare Industry: Drug Manufacturers - Specialty and Generic Market Cap: $207.71M Activated in VL: True Average Daily Range Avg Daily Range: $0.19 | 3.10% Avg Daily Range (30 D): $0.15 | 2.39% Avg Daily Range (90 D): $0.19 | 2.82% Institutional Daily Volume Avg Daily Volume: .27M Avg Daily Volume (30 D): .15M Avg Daily Volume (90 D): .17M Trade Size Avg Trade Size (Sh.): 98 Avg Trade Size (Sh.) (30 D): 65 Avg Trade Size (Sh.) (90 D): 65 Institutional Trades Total Inst.Trades: 20 Avg Inst. Trade: $2.91M Avg Inst. Trade (30 D): $4.08M Avg Inst. Trade (90 D): $1.9M Avg Inst. Trade Volume: .4M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $7.8M Avg Closing Trade (30 D): $4.08M Avg Closing Trade (90 D): $3.03M Avg Closing Volume: 1.08M     News Jan 17, 2025 @ 10:24 PM Lifecore Biomedical Announces Special Stockholder ... Source: N/A Jan 7, 2025 @ 2:00 PM Lifecore Biomedical Further Strengthens Financial ... Source: N/A Jan 3, 2025 @ 11:42 AM US Stocks Poised To Open Higher As Futures Advance... Source: Rishabh Mishra Nov 7, 2024 @ 12:00 PM Lifecore Biomedical to Host Virtual Investor Day P... Source: N/A Nov 4, 2024 @ 12:00 PM Lifecore Biomedical Appoints Thomas Guldager as Vi... Source: N/A Financials   TTM Q2 2025 Q1 2025 Basic EPS $-.5 $-.25 $-.53 Diluted EPS $-.56 $-.25 $-.53 Revenue $ 130.86M $ 32.56M $ 24.71M Gross Profit $ 45.64M $ 11.08M $ 5.39M Net Income / Loss $ -14.25M $ -6.57M $ -16.23M Operating Income / Loss $ -12.29M $ -1.96M $ -11.58M Cost of Revenue $ 85.22M $ 21.48M $ 19.32M Net Cash Flow $ 6.23M $ 3.94M $ -2.94M PE Ratio